MYC and cancer: Markedly, in contrast to the current chemotherapy agents, c‐Myc overexpressing cancer cells, which carry mutant oncogenes such as MOLM‐13 with FLT3‐ITD mutant, Mia‐paca2 with K‐ras mutant, and H1975 with EGFR mutant (T790M) are also sensitive to WBC100.